Prescription drugs; require that value of manufacturer copay assistance be applied to reduce patient deductible/out-of-pocket maximum costs.

Summary

The bill would force health benefit plans and prescription drug programs that receive manufacturer copay assistance to count that assistance against a patient’s cost‑sharing, such as deductibles and out‑of‑pocket maximums. It aims to lower the amount patients actually pay for their medicines. The measure did not pass and died in committee.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share